MedTrace Logo

Efficacy and Safety of a Hyaluronic Acid-Based Vaginal Moisturizer Medical Device to Ease Symptoms of Vaginal Dryness

NCT05888116 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2024-02-20

No results posted yet for this study

Summary

This study evaluates the efficacy and safety of a new hyaluronic acid-based vaginal moisturizer gel to ease symptoms of vaginal dryness compared to a commonly used marketed vaginal moisturizer (Cumluade Hidratante Interno®).

Conditions

  • Vaginal Disease

Interventions

DEVICE

Hidrante HA

Apply the 5 ml single dose three times a week, every other day, preferably at night before going to bed for 4 weeks.

DEVICE

Cumlaude Hidrante Interno®

Apply the 5 ml single dose three times a week, every other day, preferably at night before going to bed for 4 weeks.

Sponsors & Collaborators

  • Dermofarm, S.A.U

    lead INDUSTRY

Principal Investigators

  • Maria Fasero, Ph · Clínica Corofas. Tomelloso. Ciudad Real

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-23
Primary Completion
2023-10-18
Completion
2023-10-18

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888116 on ClinicalTrials.gov